Advertisement

FDA Chief: COVID Vaccine in Pregnancy Should Be Personal Choice

0
By I. Edwards HealthDay Reporter FRIDAY, May 30, 2025 (HealthDay News) — Federal health officials have pulled back a key recommendation that pregnant women get...

Clinical Guideline Issued for Statin Use in Persons With HIV

0

Statins recommended for persons with HIV with a 10-year ASCVD risk score of 5 percent or higher; favored for those with risk score <5 percent

ACP Issues Clinical Guideline for Statin Use in Persons With HIV

0

Statins recommended for persons with HIV with a 10-year ASCVD risk score of 5 percent or higher; favored for those with risk score <5 percent

U.S. Ends $600M Moderna Bird Flu Vaccine Contract

0
By I. Edwards HealthDay Reporter THURSDAY, May 29, 2025 (HealthDay News) — The U.S. government has canceled a $600 million contract with Moderna to develop...

Low Alcohol Use Disorder Treatment Rates Seen in Cancer Survivors

0

One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent

ASCO: GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause Death

0

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes

Odds of Cardiovascular Events Up for RSV Hospitalization Versus COVID-19 Hospitalization

0

Odds of any acute cardiovascular event increased when compared with COVID-19 hospitalizations in boosted and unboosted individuals

RFK Jr. Ends COVID Vaccine Urging for Healthy Kids, Pregnant Women

0
By I. Edwards HealthDay Reporter WEDNESDAY, May 28, 2025 (HealthDay News) — The top U.S. health agency will no longer recommend the COVID-19 vaccine for...

ASCO: Maintenance Lurbinectedin + Atezolizumab Enhances Survival in Lung Cancer

0

Findings seen for patients with extensive-stage small cell lung cancer, following standard induction therapy

FDA Approves Topical Foam for Plaque Psoriasis of the Scalp and Body

0

Approval is for once-daily 0.3 percent roflumilast topical foam for patients 12 years and older